|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
Prepublished online as a Blood First Edition Paper on July 25, 2002; DOI 10.1182/blood-2001-12-0228.
HEMATOPOIESIS
From the Division of Human Nutrition and Epidemiology,
Wageningen University, The Netherlands; the African
Medical and Research Foundation, Nairobi, Kenya; the
Department of Gastroenterology, Nijmegen University Medical Centre, The
Netherlands; and the Clinical-Chemical Laboratory, Eemland
Hospital, Amersfoort, The Netherlands.
Malarial anemia is associated with a shift in iron
distribution from functional to storage compartments. This suggests a
relative deficit in erythropoietin production or action similar to that observed in other infections. Our study in Kenyan children with asymptomatic malaria aimed at investigating whether malaria causes increased erythropoiesis, and whether the erythropoietic response appeared appropriate for the degree of resulting anemia. Longitudinal and baseline data were used from a trial with a 2 × 2 factorial design, in which 328 anemic Kenyan children were randomly assigned to
receive either iron or placebo, and sulfadoxine-pyrimethamine or
placebo. Erythropoiesis was evaluated by serum concentrations of
erythropoietin and soluble transferrin receptor. Prospectively collected data showed that malarial infection resulted in decreased hemoglobin concentrations, and increased serum concentrations of
erythropoietin and transferrin receptor. Conversely, disappearance of
malarial antigenemia resulted in increased hemoglobin concentrations, and decreased concentrations of these serum indicators. Additionally, our baseline data showed that current or recent malarial infection is
associated with increased serum concentrations of erythropoietin and
transferrin receptor, and that these were as high as or perhaps even
higher than values of children without malarial infection and without
inflammation. Our findings indicate that in asymptomatic malaria, the
erythropoietic response is adequate for the degree of anemia, and that
inflammation probably plays no or only a minor role in the pathogenesis
of the resulting anemia. Further research is needed to demonstrate the
role of deficient erythropoietin production or action in the
pathogenesis of the anemia of symptomatic malaria.
(Blood. 2002;100:3489-3494) Impaired erythropoiesis is believed to play an
important role in the pathogenesis of malarial anemia, and may
exacerbate anemia due to malaria-induced hemolysis.1
Several mechanisms might explain this erythropoietic suppression.
Malarial anemia is associated with a shift of iron distribution from
functional compartments Observational evidence supports a possible role of proinflammatory
cytokines in the pathogenesis of malarial anemia. Serum erythropoietin
concentrations are increased in acute, symptomatic malaria5-7 but appear lower than expected for the degree
of anemia.8 Proinflammatory cytokines such as TNF, IL-1,
and IL-6 are released by monocytes and suppress erythropoietin
synthesis in adults with symptomatic malaria.9-10
Similar observations have been made in children with persistent,
asymptomatic Plasmodium falciparum malaria.11
Reduced erythropoietin production or action might possibly explain
reports12 of reduced numbers of red cell precursors in acute malaria. Evidence for erythroid hypoplasia is supported by
ferrokinetic studies showing reduced incorporation of iron into red
cells during acute malaria,13 and showing decreased serum
soluble transferrin receptor (sTfR) concentrations during episodes of
febrile malaria.14,15 Concentrations of sTfR measure both
erythropoietic activity and the deficit in the erythron of iron; they
are not influenced by the inflammatory response to infections.16-18
Studies from Zaire, however, failed to show an effect on sTfR
concentrations of malaria,19,20 whereas reports from
cross-sectional studies among nonhospitalized Africans give support to
increased sTfR concentration in malaria.21-23 Erythroid
hyperplasia with dyserythropoiesis may also occur in malaria, and
appears more common in patients with severe anemia and low-grade
parasitemia than in those with acute malaria.12
We used longitudinal data to investigate whether malaria and iron
deficiency in asymptomatic Kenyan children independently cause
increased erythropoiesis. Study of pathogenic mechanisms in
asymptomatic malaria is important because there are strong indications
that mild anemia may progress to severe anemia in children with malaria
but remaining without or with few symptoms. Erythropoiesis was
evaluated by serum concentrations of erythropoietin and
sTfR.24,25 The data used were collected as part of a
randomized controlled trial to determine the efficacy in improving iron
status of intermittent administration of iron and
sulfadoxine-pyrimethamine (SP). In addition, we used the baseline data
from this trial to evaluate whether observational data indicated that
the erythropoietic response to asymptomatic malaria was appropriate for
the degree of resulting anemia. Detailed descriptions of study design
and other results are published elsewhere.26
Area and population
A research clinic was established in the area and children were
recruited from neighboring communities at the start of rainy seasons in
the period 1998 to 2000. The study received ethical approval from the
African Medical and Research Foundation and the Kenya Medical Research
Institute. Informed consent was obtained from community leaders and
local government officials, and from parents of participating children,
in accordance with the Helsinki protocol. Children included in the
study and their siblings received free medical care for common
childhood illnesses.
Design and procedures
Eligibility criteria at randomization were as follows: hemoglobin concentrations 60 g/L to 110 g/L; age 2 to 36 months; axillary temperature less than 37.50°C; absence of symptoms suggestive of malaria or anemia, or of any systemic illness occurring in combination with a dipstick test result indicating current or recent malarial infection; parents reported their intention to stay in the study area during the intervention period; parental consent given; absence reported of allergy to sulfa drugs; and no sulfa drugs used in the previous 3 weeks. Children were withdrawn and treated as appropriate if hemoglobin concentrations were less than 50 g/L, if they met one or more criteria of severe and complicated malaria,27 or if they had manifestations of other severe disease. Children were medically examined at baseline and at 12 weeks. At both visits, samples of capillary blood from each child were assayed by dipstick test to detect current or recent malarial infection, and hemoglobin concentration was measured. Children were always promptly treated for common illnesses, or referred if needed; details are described elsewhere.26 Laboratory measurements Hemoglobin concentrations were determined by photometer (HemoCue, Ängelholm, Sweden), and dipstick tests (Model ML02; AMRAD/ICT, Sydney, Australia) were used for rapid detection in blood of antigens (histidine-rich protein-2) specific to P falciparum.28 In patients with manifestations of malaria, this test has sensitivity and specificity estimates more than 95% in detecting parasitemia as determined by microscopy.29-32 A negative test result is highly predictive for the absence of malarial infection, whereas a positive test result probably has less predictive value for the presence of infection.33 Resources were lacking for routine microscopic examination of blood smears.Procedures for collection and handling of blood samples have been described elsewhere.23 Ferritin concentrations were measured by immunoassay (Roche, Mannheim, Germany) on an Elecsys electrochemiluminescense analyzer. C-reactive protein concentration was determined as an indicator of inflammation in an assay (Orion Diagnostics, Espoo, Finland) adapted to allow measurement in low volumes of ranges from zero to highly elevated values. This method correlated excellently with standard methods (Beckman Coulter, Brea, CA; Roche). Serum transferrin receptor concentrations were estimated by enzyme-linked immunosorbent assay (Ramco, DPC, Los Angeles, CA) according to instructions from the manufacturer. Erythropoietin was measured by chemiluminescent immunoassay (Diagnostic Products, Los Angeles, CA). Insufficient blood was available for determination of all hematologic indicators in all blood samples: as a result, the total number of children included in the subgroups was sometimes less than the total number of children investigated (n = 328). Statistical analysis Data cleaning and standard analysis was undertaken using SPSS (version 7.5.2; SPSS, Chicago, IL). Cross-sectional data from the baseline were used to compare blood samples testing positive and negative when assayed by malaria dipstick test with regard to hemoglobin concentration, and serum concentrations of ferritin, erythropoietin, and sTfR. Values of serum indicators were normalized by log transformation before analysis.The cross-sectional data were subsequently used to assess serum
concentrations of ferritin, erythropoietin, and sTfR in children with a
positive malaria dipstick test in comparison with what might be
expected for the resulting degrees of anemia and
inflammation.24,25 For this purpose, children were divided
into 3 groups. Group 1 comprised children whose blood tests indicated
the absence of both malarial infection and inflammation (serum
C-reactive protein concentration In a subsequent analysis, change in hematologic indicators was calculated as the difference in values after and before intervention. For serum indicators, these changes were either positively or negatively skewed within intervention groups and could not be normalized. Thus, we could not use linear regression models to evaluate the response of these indicators to malaria or iron supplementation. The effects on hematologic indicators of iron supplementation were assessed in children without malarial infection at both baseline and at 12 weeks, thus excluding children with a positive dipstick test result at either of these points in time. In addition, we excluded children receiving SP in this analysis, regardless of whether it was given alone or in combination with iron. Significance of differences in the distributions was determined by t test in the case of change in hemoglobin concentrations, and by the Mann-Whitney test in the remaining indicators. Finally, we examined the effects of asymptomatic malaria in children receiving either SP or placebo, thus excluding children receiving iron. These children were divided into 3 groups. Group A comprised children without infection at either baseline or at 12 weeks as assessed by dipstick test. Group B contained children who became infected during the trial (dipstick test result negative at baseline, and positive at 12 weeks), whereas group C comprised children with a positive dipstick test at baseline, and a negative result at 12 weeks. The results from groups B and C were both compared with those from group A, and significance of differences in the distributions were determined by the Mann-Whitney test. Data from children with a positive dipstick test both at baseline and at 12 weeks were not considered because parasite density might not have been the same at the 2 time points. Thus, it would be difficult to interpret the meaning of any differences in the parameters between these time points.
Findings from the cross-sectional data of the effect of malaria on
hematologic indicators are shown in Table
1. The prevalence of current or recent
malarial infection in these children as indicated by a positive
dipstick test result was 0%, 20%, 29%, and 50% for children aged 2 to 6 months, 6 to 12 months, 12 to 24 months, and 24 to 36 months,
respectively. Malarial infection was associated with a mild reduction
of hemoglobin concentrations, mild inflammation as indicated by serum
C-reactive protein concentration, and increased serum
concentrations of erythropoietin, sTfR, and ferritin.
Serum concentrations of erythropoietin and sTfR from children with
current or recent malarial infection as indicated by dipstick test were
as high as or perhaps even beyond the values of children without
malaria, regardless of whether serum C-reactive protein concentration
values from children in groups 1 or 2 indicated the presence or absence
of inflammation (Figure 1). Blood samples from children in group 3 had somewhat higher serum C-reactive protein concentrations than their counterparts in group 2 (not shown).
Hemoglobin concentrations increased more in children who received iron
than in their counterparts who received iron placebo (16.0 g/L versus
4.1 g/L; difference: 11.9 g/L; 95% confidence interval: 7.9-15.9 g/L).
The corresponding changes in concentrations of serum indicators are
shown in Figure 2. Iron supplementation led to decreased serum concentrations of erythropoietin and sTfR, and
increased serum ferritin concentrations. There was no evidence of an
effect of iron on serum C-reactive protein concentrations (not shown),
or of differences between the groups compared regarding baseline
characteristics (not shown).
Children who became infected by malaria in the course of the study had
decreased hemoglobin concentrations (Table
2), and increased serum concentrations of
erythropoietin, sTfR, C-reactive protein, and ferritin at 12 weeks
when compared with baseline (Figure 3).
Conversely, those with both a positive dipstick test result at baseline
and a negative dipstick test result at 12 weeks, had increased
hemoglobin concentrations (Table 2), and decreased serum concentrations
of erythropoietin, sTfR, C-reactive protein and ferritin at 12 weeks
when compared with baseline (Figure 3). Exclusion of children who
received SP did not lead to different conclusions (not shown).
Our findings showed prospectively that the development of asymptomatic malaria resulted in decreased hemoglobin concentrations, and increased serum concentrations of erythropoietin and transferrin receptor. Conversely, the disappearance of malarial antigenemia resulted in increased hemoglobin concentrations, and decreased concentrations of these serum indicators. In addition, our baseline data showed that current or recent malarial infection is associated with increased serum concentrations of erythropoietin and transferrin receptor, and that these were as high as or perhaps even higher than the values of children without malarial infection and without inflammation. Many African children presenting to hospitals with malarial infection and severe, acutely life-threatening anemia have no symptoms or recent history of symptoms of malaria attacks.34 It appears that at least in a large proportion of these children, severe anemia has developed following prolonged exposure to chronic or repeated infection with low levels of parasitemia. Likewise, reports from many community-based surveys in malaria-endemic areas indicate that a substantial proportion of children may have severe anemia. The vast majority of these children are asymptomatic, and they often have low-level parasitemia. Thus, we believe that our present report on the erythropoietic response in children with asymptomatic malaria may also contribute to understanding the pathogenesis of severe, life-threatening malarial anemia. To assess the effects of iron supplementation, we excluded from the analysis children with malarial infection at baseline or after 12 weeks to eliminate the possibility of confounding due to the effects of malaria. We observed that iron supplementation leads to both increased hemoglobin concentrations and decreased serum erythropoietin concentrations. This is in agreement with reports that iron-deficient erythropoiesis leads to appropriately increased serum concentrations of erythropoietin and hypoproliferative erythropoiesis but an impaired responsiveness to erythropoietin.35 In addition, we found that iron supplementation led to decreased sTfR concentrations. This corroborates our understanding that the expression of transferrin receptors on the cell surface of the erythroblast can be modified to reflect cellular iron requirements, resulting in an increased density of surface transferrin receptors in iron-deficient cells.18 Serum soluble transferrin receptors presumably result from cellular degradation of membrane-bound receptors. In the absence of hemolysis or other causes of increased erythroid iron turnover, increased sTfR concentrations reliably indicate iron deficiency.36 In an earlier report,37 it was shown that the dipstick test employed might give positive results for up to 2 weeks after clearance of parasitaemia. In most cases (70%), however, results became negative within 7 days after initiation of curative chemotherapy.37 In our study, such false positives may have led to misclassification of infection status at baseline, and thus to underestimates in the effect of malarial infection. Despite this possible bias, we found that a positive dipstick test result was associated with decreased hemoglobin concentrations, and with increased serum concentrations of erythropoietin, transferrin receptor and C-reactive protein (Table 1). Thus, we believe that our conclusions drawn from these and other observations (Table 2, Figures 1 and 3) are correct. In children with a negative dipstick test result at baseline, a subsequent positive dipstick test validly indicates a newly acquired infection. Malaria causes a shift of iron distribution from functional toward storage compartments,2 which has also been observed in a range of other infections.3,4,38-40 Thus, in malaria, stainable macrophage iron stores are often present in bone marrow41,42 while serum ferritin concentrations are increased.2,42,43 Ferritin is an iron storage protein, but its serum concentration also increases in infection, probably as part of a host immune response.44 This was confirmed by our results. We also found that asymptomatic malaria results in increased serum concentrations of C-reactive protein, which is a highly responsive acute phase reactant. Serum ferritin concentrations less than 12 µg/L are highly predictive of depleted iron stores,45 whereas values above this range, when coupled with anemia, indicate inflammation but may mask coexisting iron deficiency.23 Anemia, decreased or inappropriately low erythropoiesis, and the shift in iron distribution from functional to storage compartments are observed in malaria and a range of other infections. As also indicated in several other reports,44,46 this suggests that the pathogenic mechanisms underlying the anemia of chronic disease also play a role in the development of malarial anemia. Several workers raised42 and reviewed46,47 the possibility that acute, symptomatic malaria leads to iron sequestration in the mononuclear phagocyte system, thus resulting in iron-limited erythropoiesis. There are several reasons to believe that this is not the case. First, the observed presence of iron in bone marrow corroborates experimental evidence4 that iron therapy in patients with inflammatory diseases does not result in correction of anemia. Second, contrary to a state of iron deficiency, iron absorption is normal or somewhat decreased in the anemia of chronic disease,40 and absorbed iron is effectively incorporated in the erythron.48 Third, instead of being incorporated into hemoglobin, it appears that iron taken up in developing red cells is stored in ferritin and hemosiderin.48 Fourth, expression of transferrin receptors on individual erythroblasts is increased in iron deficiency but decreased in anemia of chronic disease.18,49,50 If our assumption were true that also asymptomatic malaria does not lead to iron sequestration, then this would suggest that the increased serum transferrin receptor concentrations observed in children with malarial infection in our study are primarily due to increased erythropoiesis. The anemia of chronic disease is primarily due to reduced erythropoietin production and reduced responsiveness of erythroid progenitor cells to erythropoietin3,4 under influence of proinflammatory cytokines such as tumor necrosis factor and interleukin-1. Therapy using recombinant erythropoietin can correct the anemia of chronic disease but not of iron deficiency.3 Thus, the distinctive abnormalities in body iron distribution appear to be a by-product of these mechanisms.51 It cannot be ruled out, however, that some iron sequestration occurs in malaria in hemazoin, a product from hemoglobin degradation by malaria parasites that is found in circulating or phagocytosed red cells. Contrary to what is observed in the anemia of chronic disease,3,4 we found no evidence that erythropoietin production was impaired in asymptomatic malaria (Figure 1). In addition, serum transferrin receptor concentrations in children with current or recent malarial infection appeared appropriate for the degree of anemia (Figure 1). In a study among asymptomatic children, Mockenhaupt et al21 also reported increased serum transferrin receptor concentrations when adjusting for hemoglobin concentration. These findings provide evidence that the erythropoietic response of asymptomatic malaria is adequate for the degree of anemia, and that inflammation probably plays no or only a minor role in the pathogenesis. This indicates that the malaria-associated anemia observed in the present study is primarily due to hemolysis. We found that a positive dipstick test result was associated with a minor increase in serum C-reactive protein concentration, indicating that malarial infection was associated with a minor degree of inflammation. Acute malaria is probably associated with higher parasite densities and thus more intense inflammation. Thus, it seems likely that the decrease in sTfR concentrations observed in acute malaria14,15 might be due, in addition to hemolysis, to deficient erythropoietin production or suppressed marrow response to erythropoietin. In summary, our findings indicate that in asymptomatic malaria, the erythropoietic response is adequate for the degree of resulting anemia. Inflammation and the pathogenic mechanisms involved in the anemia of chronic disease probably play no or a minor role. Further research is needed to demonstrate the role of deficient erythropoietin production or action in the pathogenesis of the anemia of acute, symptomatic malaria.
H.V., C.E.W., and F.J.K. were responsible for study design and interpretation of results. R.K. was responsible for biochemical analyses and assisted in the interpretation of their results. H.V. carried out the data analysis. H.V., S.M.N., R.K., M.M.M., S.van L., R.H., and C.S. collected the data. We are grateful for outstanding assistance by Pascal Kyulle and Jones Mwau, chiefs of Kathekani and Nthunguni locations, respectively, as well as village elders, community health workers, traditional birth attendants, and the parents of study children. In addition, we thank Mike Aballa Wanga, Jacobien Veenemans, Rikkert van der Valk, Anneleen Kuijsten, Stefan de Vogel, Mariëlle Maas, and Shanomae Rose for excellent assistance in data collection, and Riekie te Stroet, medical technican, Eemland Hospital, Amersfoort, The Netherlands, for biochemical analyses of serum samples.
Submitted March 14, 2002; accepted June 7, 2002.
Prepublished online as Blood First Edition Paper, July 25, 2002; DOI 10.1182/blood-2001-12-0228.
Supported by the Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO; grant WV93-273).
Correspondence: Clive E. West, Division of Human Nutrition and Epidemiology, Wageningen University, PO Box 8129, 6700 EV Wageningen, The Netherlands; e-mail: clive.west{at}staff.nutepi.wau.nl.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
1. Menendez C, Fleming AF, Alonso PL. Malaria-related anaemia. Parasitol Today. 2000;16:469-476[CrossRef][Medline] [Order article via Infotrieve]. 2. Das BS, Thurnham DI, Das DB. Influence of malaria on markers of iron status in children: implications for interpreting iron status in malaria-endemic communities. Br J Nutr. 1997;78:751-760[CrossRef][Medline] [Order article via Infotrieve].
3.
Means RT, Krantz SB.
Progress in the understanding the pathogenesis of the anemia of chronic disease.
Blood.
1992;80:1639-1647 4. Spivak JL. The blood in systemic disorders. Lancet. 2000;355:1707-1712[CrossRef][Medline] [Order article via Infotrieve].
5.
Burchard G-D, Radloff P, Phillips J, Nkeyi M, Knobloch J, Kremsner PG.
Increased erythropoietin production in children with severe malarial anemia.
Am J Trop Med Hyg.
1995;53:547-551
6.
Burgmann H, Looareesuwan S, Kapiotis S, et al.
Serum levels of erythropoietin in acute Plasmodium falciparum malaria.
Am J Trop Med Hyg.
1996;54:280-283 7. Kurtzhals JA, Rodrigues O, Addae M, Commey JO, Nkumrah FK, Hviid L. Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria. Br J Haematol. 1997;97:169-174[CrossRef][Medline] [Order article via Infotrieve].
8.
Vedovato M, De Paoli Vitali E, Dapporto M, Salvatorelli G.
Defective erythropoietin production in the anaemia of malaria.
Nephrol Dial Transplant.
1999;14:1043-1044 9. Clark IA, Chaudhri G. Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br J Haematol. 1988;70:99-103[Medline] [Order article via Infotrieve]. 10. Clark IA, Chaudhri G, Cowden WB. Roles of tumour necrosis factor in the illness and pathology of malaria. Trans R Soc Trop Med Hyg. 1989;83:436-440[CrossRef][Medline] [Order article via Infotrieve]. 11. Kurtzhals JA, Addae M, Akanmori BD, et al. Anaemia caused by asymptomatic Plasmodium falciparum infection in semi-immune African schoolchildren. Trans R Soc Trop Med Hyg. 1999;93:623-627[CrossRef][Medline] [Order article via Infotrieve]. 12. Abdalla SH. Hematopoiesis in human malaria. Blood Cells. 1990;16:401-416[Medline] [Order article via Infotrieve].
13.
Srichaikul T, Poshyachinda V, Panikbutr N, Rabieb T.
Ferrokinetic studies and erythropoiesis in malaria.
Arch Intern Med.
1969;124:623-628 14. Williams TN, Maitland K, Rees DC, et al. Reduced soluble transferrin receptor concentrations in acute malaria in Vanuatu. Am J Trop Med Hyg. 1999;60:875-878[Abstract]. 15. Beesley R, Filteau S, Tomkins A, et al. Impact of acute malaria on plasma concentrations of transferrin receptors. Trans R Soc Trop Med Hyg. 2000;94:295-298[CrossRef][Medline] [Order article via Infotrieve]. 16. Cook JD, Skikne BS, Baynes RD. Serum transferrin receptor. Annu Rev Med. 1993;44:63-74[CrossRef][Medline] [Order article via Infotrieve]. 17. Cook JD, Skikne B, Baynes R. The use of the serum transferrin receptor for the assessment of iron status. In: Hallberg L,Asp G-G, eds. Iron Nutrition in Health and Disease. London United Kingdom: John Libbey & Company; 1996:49-58. 18. Feelders RA, Kuiper-Kramer EP, Van Eijk HG. Structure, function and clinical significance of transferrin receptors. Clin Chem Lab Med. 1999;37:1-10[CrossRef][Medline] [Order article via Infotrieve]. 19. Kuvibidila S, Mark JA, Warrier RP, Yu L, Ode D, Tshefu KA. Soluble transferrin receptor as an index of iron status in Zairian children with malaria. J Trop Med Hyg. 1995;98:373-378[Medline] [Order article via Infotrieve].
20.
Kuvibidila S, Warrier RP, Ode D, Yu L, Tsefu KA.
Lack of difference in iron status assessed by soluble transferrin receptor between children with cerebral malaria and those with non-cerebral malaria.
J Trop Pediatr.
1999;45:166-167 21. Mockenhaupt FP, May J, Stark K, Falusi AG, Meyer CG, Bienzle U. Serum transferrin receptor levels are increased in asymptomatic and mild Plasmodium falciparum-infection. Haematol. 1999;84:869-873.
22.
Stoltzfus RJ, Chwaya HM, Montresor A, Albonico M, Savioli L, Tielsch JM.
Malaria, hookworms and recent fever are related to anemia and iron status indicators in 0- to 5-y old Zanzibari children and these relationships change with age.
J Nutr.
2000;130:1724-1733
23.
Verhoef H, West CE, Ndeto P, Burema J, Beguin Y, Kok FJ.
Serum transferrin receptor concentration indicates increased erythropoiesis in Kenyan children with asymptomatic malaria.
Am J Clin Nutr.
2001;74:767-775 24. Barosi G. Inadequate erythropoietin response to anemia: definition and clinical relevance. Ann Hematol. 1994;68:215-223[CrossRef][Medline] [Order article via Infotrieve].
25.
Beguin Y, Clemons GK, Pootrakul P, Fillet G.
Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin.
Blood.
1993;81:1067-1076 26. Verhoef H, West CE, Nzyuko SM, et al. Intermittent administration of iron and sulfadoxine-pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet. In press. 27. Warrell DA, Molyneux ME, Beales PF. Severe and complicated malaria. Trans R Soc Trop Med Hyg. 1990;84:1-65[Medline] [Order article via Infotrieve]. 28. Anonymous. New perspectives: malaria diagnosis. Report of a joint WHO/USAID informal consultation (27-29 October 1999). Geneva: World Health Organization; 2000. 29. Durrheim DN, la Grange JJ, Govere J, Mngomezulu NM. Accuracy of a rapid immunochromatographic card test for Plasmodium falciparum in a malaria control programme in South Africa. Trans R Soc Trop Med Hyg. 1998;92:32-33[CrossRef][Medline] [Order article via Infotrieve]. 30. Garcia M, Kirimoama S, Marlborough D, Leafasia J, Rieckmann KH. Immunochromatographic test for malaria diagnosis [letter]. Lancet. 1996;347:1549[Medline] [Order article via Infotrieve]. 31. Kilian AH, Mughusu EB, Kabagambe G, von Sonnenburg F. Comparison of two rapid, HRP2-based diagnostic tests for Plasmodium falciparum. Trans R Soc Trop Med Hyg. 1997;91:666-667[CrossRef][Medline] [Order article via Infotrieve]. 32. Kumar A, Sharma VP, Thavaselvam D, Sumodan PK. Clinical trials of a new immunochromatographic test for diagnosis of Plasmodium falciparum malaria in Goa. Indian J Malariol. 1996;33:166-172[Medline] [Order article via Infotrieve]. 33. Eisen DP, Saul A. Disappearance of pan-malarial antigen reactivity using the ICT Malaria P.f/P.v kit parallels decline of patent parasitaemia as shown by microscopy. Trans R Soc Trop Med Hyg. 2000;94:169-170[CrossRef][Medline] [Order article via Infotrieve]. 34. Abdalla S, Weatherall DJ, Wickramasinghe SN, Hughes M. The anaemia of P falciparum malaria. Br J Haematol. 1980;46:171-183[Medline] [Order article via Infotrieve]. 35. Baynes RD. Iron deficiency. In: Brock JH,Halliday JW,Pippard MJ,Powell LW, eds. Iron Metabolism in Health and Disease. London United Kingdom: WB Saunders; 1994:189-225. 36. Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med. 1992;119:385-390[Medline] [Order article via Infotrieve]. 37. Singh N, Valecha N, Sharma VP. Malaria diagnosis by field workers using an immunochromatographic test. Trans R Soc Trop Med Hyg. 1997;91:396-397[CrossRef][Medline] [Order article via Infotrieve]. 38. Sears DA. Anemia of chronic disease. Med Clin North Am. 1992;76:567-579[Medline] [Order article via Infotrieve]. 39. Konijn A. Iron metabolism in inflammation. Baillieres Clin Haematol. 1994;7:829-849[CrossRef][Medline] [Order article via Infotrieve]. 40. Jurado RL. Iron, infections, and anemia of inflammation. Clin Infect Dis. 1997;25:888-895[Medline] [Order article via Infotrieve]. 41. Abdalla SH. Iron and folate status in Gambian children with malaria. Ann Trop Paediatr. 1990;10:265-272[Medline] [Order article via Infotrieve]. 42. Phillips RE, Looareesuwan S, Warrell DA, et al. The importance of anaemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestration. Q J Med. 1986;58:305-323[Medline] [Order article via Infotrieve]. 43. Oppenheimer SJ, Worwood M, Bull R. Source of serum ferritin in malaria [letter]. Ann Trop Paediatr. 1984;4:251[Medline] [Order article via Infotrieve]. 44. Kent S, Weinberg ED, Stuart Macadam P. The etiology of the anemia of chronic disease and infection. J Clin Epidemiol. 1994;47:23-33[CrossRef][Medline] [Order article via Infotrieve].
45.
Skikne BS, Flowers CH, Cook JD.
Serum transferrin receptor: a quantitative measure of tissue iron deficiency.
Blood.
1990;75:1870-1876 46. Weatherall DJ, Abdalla S, Pippard MJ. The anaemia of Plasmodium falciparum malaria. Ciba Found Symp. 1983;94:74-97[Medline] [Order article via Infotrieve]. 47. Phillips RE, Pasvol G. Anaemia of Plasmodium falciparum malaria. Baillieres Clin Haematol. 1992;5:315-330[Medline] [Order article via Infotrieve].
48.
Pollack S.
Iron and the anemia of chronic disease [letter].
Blood.
1992;80:3252 49. Kuiper-Kramer PA, Coenen JL, Huisman CMS, Abbes A, Van Raan J, Van Eijk HG. Relationship between soluble transferrin receptors in serum and membrane-bound transferrin receptors. Acta Haematol. 1998;99:8-11[CrossRef][Medline] [Order article via Infotrieve]. 50. Kuiper-Kramer PA, Huisman CMS, Van der Molen-Sinke J, Abbes A, Van Eijk HG. The expression of transferrin receptors on erythroblasts in anaemia of chronic disease, myeloplastic syndromes and iron deficiency. Acta Haematol. 1997;97:127-131[Medline] [Order article via Infotrieve]. 51. Walter T, Olivares M, Pizarro F, Muños C. Iron, anemia, and infection. Nutr Rev. 1997;55:111-124[Medline] [Order article via Infotrieve].
© 2002 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
 |
|
  J. W. McMurdy, G. D. Jay, S. Suner, and G. Crawford Noninvasive Optical, Electrical, and Acoustic Methods of Total Hemoglobin Determination Clin. Chem., February 1, 2008; 54(2): 264 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Lamikanra, D. Brown, A. Potocnik, C. Casals-Pascual, J. Langhorne, and D. J. Roberts Malarial anemia: of mice and men Blood, July 1, 2007; 110(1): 18 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Doherty Host-Pathogen Interactions: The Role of Iron J. Nutr., May 1, 2007; 137(5): 1341 - 1344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Casals-Pascual, O. Kai, J. O. P. Cheung, S. Williams, B. Lowe, M. Nyanoti, T. N. Williams, K. Maitland, M. Molyneux, C. R. J. C. Newton, et al. Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo Blood, October 15, 2006; 108(8): 2569 - 2577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E Cusick, J. M Tielsch, M. Ramsan, J. K Jape, S. Sazawal, R. E Black, and R. J Stoltzfus Short-term effects of vitamin A and antimalarial treatment on erythropoiesis in severely anemic Zanzibari preschool children Am. J. Clinical Nutrition, August 1, 2005; 82(2): 406 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-H. Chang, M. Tam, and M. M. Stevenson Inappropriately low reticulocytosis in severe malarial anemia correlates with suppression in the development of late erythroid precursors Blood, May 15, 2004; 103(10): 3727 - 3735. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2002 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
Top
Abstract
Introduction
comprising metabolically active iron that is
required for normal functions
1 body weight,
wk
10 mg/L). Group 2 comprised
children without malarial infection as indicated by a negative dipstick
test result, and with inflammation (serum C-reactive protein
concentration > 10 mg/L). Group 3 comprised children with current
or recent malarial infection as indicated by a positive dipstick test
result. Hemoglobin classes were defined using cutoff values that were
selected to balance the number of children in categories formed by
cross-tabulation with the groups into which children had been divided.
Serum concentrations of ferritin, erythropoietin, and sTfR from group 3 were subsequently compared with those from groups 1 and 2, assuming
independent t-distributions of log-transformed values.
